0001104659-16-131001.txt : 20160705 0001104659-16-131001.hdr.sgml : 20160705 20160705161544 ACCESSION NUMBER: 0001104659-16-131001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160630 FILED AS OF DATE: 20160705 DATE AS OF CHANGE: 20160705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dhanda Rahul CENTRAL INDEX KEY: 0001667658 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 161750642 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 a4.xml 4 X0306 4 2016-06-30 0 0001492674 T2 Biosystems, Inc. TTOO 0001667658 Dhanda Rahul 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 SVP of Corporate Development Common Stock 2016-06-30 4 M 0 3589 2.45 A 3589 D Common Stock 2016-06-30 4 S 0 3589 8.16 D 0 D Stock Option (Right to Buy) 2.45 2016-06-30 4 M 0 3589 0 D 2016-01-17 2022-01-17 Common Stock 3589 31705 D The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016. The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.15 to $8.24. The reporting person undertakes to provide upon request the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Michael Gibbs Attorney-in-fact 2016-07-05